Anticoagulants for heart disease
Malcolm, A.D.
British Journal of Hospital Medicine 23(6): 606; 609
1980
ISSN/ISBN: 0007-1064 PMID: 7437599 Document Number: 160416
Document emailed within 1 workday
Related Documents
Montalescot, G.; Grosgogeat, Y. 1992: The cardiologist and anticoagulants: the heart has its reasons Presse Medicale 21(9): 409-412Dettori, A.G.; Manotti, C. 1990: Oral anticoagulants and antiaggregants in heart valve prostheses Giornale Italiano di Cardiologia 20(8): 758-765
Dattino, R.; Niccoli, V.; Silvestri, C.; Dattino, M. 1989: Use of anticoagulants in pregnant women carrying heart valve prosthesis La Clinica Terapeutica 128(6): 401-404
Bussey, H.I. 2004: An overview of anticoagulants, antiplatelet agents, and the combination in patients with mechanical heart valves Journal of Heart Valve Disease 13(3): 319-324
Klinger, A.D.; Perez, A. 1972: Anticoagulants in sickle cell disease Journal of the National Medical Association 64(3): 200
Jornayvaz, F.R.; Perrier, A. 2006: Anticoagulants and cancer: beyond thromboembolic disease prevention Revue Medicale Suisse 2(83): 2350-2353
Gianetti, J.; Gensini, G.; De Caterina, R. 1998: A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants Thrombosis and Haemostasis 80(6): 887-893
Exner, T.; Triplett, D.A.; Taberner, D.; Machin, S.J. 1991: Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants Thrombosis and Haemostasis 65(3): 320-322
Yarnell, J.W.; Limb, E.S.; Layzell, J.M.; Baker, I.A. 1992: Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies European Heart Journal 13(12): 1602-1605
Kittel, F.; Kornitzer, M.; De Backer, G.; Dramaix, M. 1982: The Belgian Heart Disease Prevention Project: type A behavior pattern and the prevalence of coronary heart disease Activitas Nervosa Superior Suppl. 3(Pt 1): 78-83
Shoĭkhet, I.N.; Klester, E.B.; Golovin, V.A. 2008: Heart rhythm disturbances in patients with chronic obstructive pulmonary disease in aggregate with coronary heart disease Klinicheskaia Meditsina 86(3): 21-26
Breddin, J.; Hess, H. 1981: Should one employ anticoagulants or platelet inhibitors in the long-term prophylaxis, with or without surgery, of arterial occlusive disease? Die Medizinische Welt 32(37): 1343-1344
Bonatti, V.; Agnetti, A.; Squarcia, U. 1998: Early and late postoperative complete heart block in pediatric patients submitted to open-heart surgery for congenital heart disease La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 20(3): 181-186
Amosov, N.M.; Knyshov, G.V.; Mintser, O.P.; Ugarov, B.N.; Kononenko, I.N. 1982: Dynamics of cardiac minute volume in the diagnosis of heart failure in acquired heart defects and ischemic heart disease in the postoperative period Kardiologiia 22(10): 21-23
Pribylov, S.A. 2006: Pulmonary hypertension, endothelial dysfunction, and their correction with lisinopril in patients with heart failure in combination of ischemic heart disease and chronic obstructive pulmonary disease Kardiologiia 46(9): 36-40
Lichodziejewska, B. 1993: Management of patients with valvular heart disease and poor ventricular function. the Working Group on Valvular Heart Disease Kardiologia Polska 39(10): 316-317
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Goldbourt, U.; Yaari, S.; Medalie, J.H. 1993: Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study Cardiology 82(2-3): 100-121
Gohlke-Bärwolf, C.; Acar, J.; Oakley, C.; Butchart, E.; Burckhart, D.; Bodnar, E.; Hall, R.; Delahaye, J.P.; Horstkotte, D.; Krémer, R. 1995: Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology European Heart Journal 16(10): 1320-1330
Akhmineeva, A.K. 2014: Biochemical markers of endothelial dysfunction in chronic obstructive pulmonary disease concurrent with hypertensive disease or coronary heart disease Terapevticheskii Arkhiv 86(3): 20-23